Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Ferdinandy

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
Free Radical Biology & Medicine|October 24, 2012
Does nitric oxide signaling differ in pre- and post-conditioning? Importance of S-nitrosylation vs. protein kinase G activationRainer Schulz, Peter Ferdinandy
British Journal of Pharmacology|July 6, 2013
Nitrite in organ protectionTienush Rassaf, Peter Ferdinandy, Rainer Schulz
Journal of Molecular and Cellular Cardiology|March 19, 2013
May 2013 sees the celebration of the 80th Birthday of Lionel Opie, founder of the Journal of Molecular and Cellular CardiologySandrine Lecour, Peter Ferdinandy, David Eisner
Current Heart Failure Reports|March 2, 2024
Cellular Alterations in Immune Checkpoint Inhibitor Therapy-Related Cardiac DysfunctionLars Michel, Peter Ferdinandy, Tienush Rassaf
Current Research in Pharmacology and Drug Discovery|December 15, 2021
Is it the time of seno-therapeutics application in cardiovascular pathological conditions related to ageing?Carmela Rita Balistreri, Rosalinda Madonna, Peter Ferdinandy
Pharmacological Reviews|December 1, 2007
Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioningPeter Ferdinandy, Rainer Schulz, Gary F Baxter
Molecular Biotechnology|May 10, 2013
Glucose metabolism, hyperosmotic stress, and reprogramming of somatic cellsRosalinda Madonna, Aniko Görbe, Peter Ferdinandy, et al.
American Journal of Physiology. Heart and Circulatory Physiology|September 20, 2015
Drug-induced mitochondrial dysfunction and cardiotoxicityZoltán V Varga, Peter Ferdinandy, Lucas Liaudet, et al.
British Journal of Pharmacology|March 19, 2016
New aspects of p66Shc in ischaemia reperfusion injury and other cardiovascular diseasesFabio Di Lisa, Marco Giorgio, Peter Ferdinandy, et al.
Pharmacological Reports : PR|September 29, 2007
Inhibition of NAD(P)H oxidase attenuates aggregation of platelets from high-risk cardiac patients with aspirin resistanceGyorgyi Stef, Anna Csiszar, Zhao Ziangmin, et al.
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Free Radical Biology & Medicine|October 24, 2012
Does nitric oxide signaling differ in pre- and post-conditioning? Importance of S-nitrosylation vs. protein kinase G activationRainer Schulz, Peter Ferdinandy
British Journal of Pharmacology|July 6, 2013
Nitrite in organ protectionTienush Rassaf, Peter Ferdinandy, Rainer Schulz
Journal of Molecular and Cellular Cardiology|March 19, 2013
May 2013 sees the celebration of the 80th Birthday of Lionel Opie, founder of the Journal of Molecular and Cellular CardiologySandrine Lecour, Peter Ferdinandy, David Eisner
Current Heart Failure Reports|March 2, 2024
Cellular Alterations in Immune Checkpoint Inhibitor Therapy-Related Cardiac DysfunctionLars Michel, Peter Ferdinandy, Tienush Rassaf
Current Research in Pharmacology and Drug Discovery|December 15, 2021
Is it the time of seno-therapeutics application in cardiovascular pathological conditions related to ageing?Carmela Rita Balistreri, Rosalinda Madonna, Peter Ferdinandy
Pharmacological Reviews|December 1, 2007
Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioningPeter Ferdinandy, Rainer Schulz, Gary F Baxter
Molecular Biotechnology|May 10, 2013
Glucose metabolism, hyperosmotic stress, and reprogramming of somatic cellsRosalinda Madonna, Aniko Görbe, Peter Ferdinandy, et al.
American Journal of Physiology. Heart and Circulatory Physiology|September 20, 2015
Drug-induced mitochondrial dysfunction and cardiotoxicityZoltán V Varga, Peter Ferdinandy, Lucas Liaudet, et al.
British Journal of Pharmacology|March 19, 2016
New aspects of p66Shc in ischaemia reperfusion injury and other cardiovascular diseasesFabio Di Lisa, Marco Giorgio, Peter Ferdinandy, et al.
Pharmacological Reports : PR|September 29, 2007
Inhibition of NAD(P)H oxidase attenuates aggregation of platelets from high-risk cardiac patients with aspirin resistanceGyorgyi Stef, Anna Csiszar, Zhao Ziangmin, et al.
Pageof 7